Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

Cinda Mclaughlin v. Glaxosmithkline

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA


October 17, 2012

CINDA MCLAUGHLIN, PLAINTIFF,
v.
GLAXOSMITHKLINE, L.L.C., CADILA HEALTHCARE, ZYDUS PHARMACEUTICALS, AND APOTEX, INC. DEFENDANT.

The opinion of the court was delivered by: Ronald L. Buckwalter, S.J.

ORDER AND NOW, this 17thday of October, 2012, upon consideration of (1) the Motion by Defendant GlaxoSmithKline, LLC. to Transfer Venue to the United States District Court for the Western District of Louisiana (Docket No. 7), the Response in Opposition by Plaintiff Cinda McLaughlin (Docket No. 20), Plaintiff's Supplemental Response in Opposition (Docket No. 25), Defendant's Reply Brief in Support (Docket No. 29), and Plaintiff's Sur-Reply Brief in Opposition (Docket No. 38); and (2) Plaintiff's Motions to Voluntarily Dismiss Defendants Cadila Healthcare, Zydus Pharmaceuticals, and Apotex Inc. (Docket Nos. 34--36), it is hereby ORDERED as follows:

1. All claims against Defendants Cadila Healthcare, Zydus Pharmaceuticals, and Apotex Inc. are hereby DISMISSED without prejudice.

2. Defendant's Motion to Transfer is GRANTED. This case shall be TRANSFERRED to the United States District Court for the Western District of Louisiana.

BY THE COURT:

Ronald L. Buckwalter

20121017

© 1992-2012 VersusLaw Inc.



Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.